Obagi Medical hand sanitizer label centers on 66% ethanol and OTC monograph status
DailyMed’s current label for OBAGI MEDICAL HAND SANITIZER LAVENDER identifies the product as an alcohol gel with ethanol 66% as the active ingredient. In practical terms, that concentration sits squarely in the range used for antiseptic hand rubs designed to reduce bacterial burden on the hands. The label classifies the product as a human OTC drug and places it under an OTC monograph drug citation, which means its use is governed by established over-the-counter standards rather than a bespoke prescription pathway.
The purpose is straightforward: antiseptic hand hygiene. The stated use is to help decrease bacteria on the hands, and the directions reflect the familiar mechanics of alcohol-based sanitation—dispense a small amount onto the palms, rub lightly until dry, and do not rinse. That sequence matters because alcohol requires direct contact time on the skin surface to exert its antiseptic effect; premature wiping or rinsing short-circuits the process. In a clinical and public-health context, the value of a hand sanitizer like this depends less on branding than on whether users actually allow the product to evaporate after full coverage.
The formulation also includes a set of inactive ingredients that shape the sensory profile and skin feel: glycerin, dimethicone, carbomer, aminomethyl propanol, lavender oil, jojoba oil, and water. Glycerin and dimethicone are especially relevant in routine use because alcohol can dry the skin, and frequent hand hygiene often produces irritant dermatitis in real-world settings. A gel base that incorporates emollient or humectant components may help offset some of that dryness, though it does not eliminate the irritant potential of repeated alcohol exposure. The lavender fragrance gives the product its distinctive identity, but it also introduces a typical cosmetic-variable consideration: scented products can be better tolerated by some users and less tolerated by others.
The warning language is the part clinicians and consumers should read with equal care. The product is flammable and should be kept away from fire or flame. It is for external use only. Eye exposure should be avoided, and if the gel gets into the eyes, the label instructs immediate and thorough rinsing with water. If swallowed, medical help or poison control should be contacted right away. If irritation develops, use should stop and a doctor should be consulted. Those warnings are not boilerplate in a trivial sense; they reflect the pharmacology of alcohol itself, which is highly effective against microbes on skin and equally capable of causing mucosal injury, chemical irritation, or fire risk when misused.
Packaging details, inactivated NDCs, and what the label revision means in practice
The label lists three packaging presentations tied to the product code NDC 62032-004: a 59 mL plastic bottle, a 237 mL dispensing bottle, and a 473 mL dispensing bottle. A boxed configuration is also identified for one of the packaging entries. The principal display panel describes the 473 mL bottle as 16 fl. oz., which helps align the label’s formal product data with the physical presentation most users will recognize on store shelves or clinic counters.
One of the more important regulatory details is the presence of inactivated NDC codes. The listed NDCs 62032-004-18, 62032-004-19, and 62032-004-33 are marked inactivated under an FDA compliance action. That does not change the underlying chemistry of ethanol as an antiseptic, but it does matter for supply chain tracking, inventory reconciliation, and product-label continuity. For pharmacies, distributors, and institutional purchasers, an inactivated code can affect how a product is identified in databases and how older stock is distinguished from current labeling records.
The label shows a marketing start date of 08/31/2020 and a marketing end date of 12/31/2027 for the listed packaging entries, with the current published version dated October 15, 2026 and the drug label information updated October 13, 2026. Those dates place the product in a long-running commercial window rather than a short-lived emergency release. The manufacturing entry names G. S. Cosmeceutical USA, Inc. as the establishment responsible for manufacture of the product tied to the labeler, Obagi Cosmeceuticals LLC.
For bedside use, the most relevant takeaway is not the labeler identity but the way the product fits into infection prevention routines. Alcohol-based sanitizers remain a core tool for hand hygiene because they are portable, quick-drying, and immediately available when soap and water are not practical. Their limitations are equally concrete: they must be used on clean, adequately covered hands, they do not replace handwashing when hands are visibly soiled, and they require careful storage because of flammability. The storage instruction on this label is specific as well—keep the product below 105°F, or 40°C—which is consistent with the need to preserve product stability and minimize volatility risks.
The label does not provide clinical trial data, comparative efficacy claims, or outcome metrics, and it does not need to do so for a monograph-based antiseptic. Its significance lies in standardized composition, clear safety language, and packaging traceability. In a crowded over-the-counter market, those are the details that determine whether a sanitizer is usable, identifiable, and appropriately handled at the point of care or at home.